DURECT Corporation DRRX
$ 1.23
-4.65%
Quarterly report 2024-Q2
added 08-14-2024
Country |
USA |
IPO year |
2000 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. James Brown |
Employees in the company |
95 |
Shares |
26.3 M |
Market Cap[1] |
$ 32.3 M |
EBITDA (LTM) |
$ -29.8 M |
P/E (LTM) |
-1.41 |
P/S (LTM) |
4.46 |
EPS (LTM) |
-0.94 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.